The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity-Reference-Cited by-同舟云学术

The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity

Published:2009-06-04 Issue:3 Volume:330 Page:932-938
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Alley Stephen C.,Zhang Xinqun,Okeley Nicole M.,Anderson Martha,Law Che-Leung,Senter Peter D.,Benjamin Dennis R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates

2. Determination of pharmacokinetic values of calicheamicin-antibody conjugates in mice by plasmon resonance analysis of small (5 μl) blood samples

3. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice

4. Potent antibody therapeutics by design

5. Antibody-Drug Conjugates for Cancer Therapy

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Principles of Antibody Drug Development;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma;The Journal of Immunology;2023-10-01

3. SGN-B6A: A New Vedotin Antibody–Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications;Molecular Cancer Therapeutics;2023-08-24

4. Antibody-Drug Conjugates in Lung Cancer: Recent Advances and Implementing Strategies;Journal of Clinical Oncology;2023-07-20

5. Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates;Drug Metabolism and Disposition;2023-06-08